Alginate in Wound Dressings.
Aderibigbe BA, Buyana B. · 2018
Read Alginate in Wound Dressings. by Aderibigbe BA, Buyana B. (2018) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6027439.txt.
Introduction
Aderibigbe and Buyana review alginate in wound dressings. Their article appeared in Pharmaceutics. Alginate is a natural polymer from seaweed sources. It is non-toxic and sits well with body tissue. Those traits make it attractive for wound care.
Dressings made from alginate soak up excess wound fluid. They keep the wound moist while limiting infection. The review covers many material forms. Hydrogels, films, wafers, and foams all appear. So do nanofibres and topical mixes. Results from lab and animal studies are summed up. Added polymers, cross linkers, and antibacterial agents shape results. Readers get a full guide to designing alginate dressings.
Catalog record
| CREATOR | Aderibigbe BA, Buyana B. |
|---|---|
| YEAR | 2018 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 73 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Alginate in Wound Dressings By Blessing Atim Aderibigbe, Buhle Buyana Published in: Pharmaceutics DOI: 10.3390/pharmaceutics10020042 ABSTRACT Alginate is a biopolymer used in a variety of biomedical applications due to its favourable properties, such as biocompatibility and non-toxicity. It has been particularly attractive in wound healing applications to date. It can be tailored to materials with properties suitable for wound healing. Alginate has been used to prepare different forms of materials for wound dressings, such as hydrogels, films, wafers, foams, nanofibres, and in topical formulations. The wound dressings prepared from alginate are able to absorb excess wound fluid, maintain a physiologically moist environment, and minimize bacterial infections at the wound site. The therapeutic efficacy of these wound dressings is influenced by the ratio of other polymers used in combination with alginate, the nature of cross linkers used, the time of crosslinking, nature of excipients used, the incorporation of nanoparticles, and antibacterial agents. This review provides a comprehensive overview of the different forms of wound dressings containing alginate, in vitro, and in vivo results. 1. INTRODUCTION The management of wound remains a challenge despite the progress made so far in the development of wound dressing materials and the level of professional discipline or experience in the field of wound management. Wounds can be classified based on their location, aetiology, nature of the injury, depth, and their appearance [1]. Generally, wounds can be classified as full thickness, partial thickness, and superficial [1,2]. The cost of management of wounds is high and the increasing population size and urban lifestyle is a pointer to the pressing need to develop wound dressings that are effective, appropriate, and affordable. In England, a cost of 184 million pounds was spent on dressing products in 2012 [3]. In the United States of America (USA), an annual cost of 20 billion dollars is spent on the management of chronic wounds [4,5]. The barriers to effective treatment of wounds can be classified as educational, organizational, clinical, and psychosocial [6] (Table 1). Wound dressings are prepared from biopolymers, synthetic polymers and biomaterials. Biopolymers such as chitosan, alginate, fucoidan, hyaluronic acid, etc. are non-toxic, readily available, biodegradable, biocompatible, and non-immunogenic [7,8]. Alginate application in wound dressings is due to its unique properties, such as non-toxicity, biocompatibility, non-immunogenicity, affordability, and high absorption capacity [9]. However, biopolymers are generally limited by their poor mechanical properties. They are combined with synthetic polymers in order to enhance their mechanical properties and tailored to modify their degradation pattern [7,8]. Wound dressings come in different forms and the common problems associated with some of the currently used wound dressings include their inability to maintain a moist environment; poor absorption of wound exudates; delayed wound healing process (i.e., connective tissue synthesis, epidermal migration, and angiogenesis); poor gas exchange between wound and the environment; lack of protection against bacterial infection; difficulty in removal of the wound dressing after healing; and, non-sterile and allergic reactions [10]. The unique properties of alginate make it a potential biopolymer that can overcome the problems in currently used wound dressing by enhancing absorption of wound exudates and minimizing bacterial infections, reducing adverse allergic effects, and improving wound healing because of its biocompatibility, etc. It also exhibits hemostatic properties, which are useful for bleeding wounds [11]. In the design of wound dressings, the important factors that must be taken into consideration are their ability to reduce infections, stop bleeding, absorb exudates, enhance healing and wound debridement, easy to use, biodegradability, easily sterilised, non-toxicity, good water vapour, and gas permeability [12]. Wound dressings can be classified as artificial, traditional, and biomaterial-based dressings [12]. This manuscript will provide a comprehensive overview of the different forms of wound dressings containing alginate, in vitro and in vivo results. 2. WOUND HEALING PROCESS Wounds can be classified as chronic and acute wounds based on the wound healing process [13]. Chronic wounds are caused by age, obesity, injuries, and chronic conditions, such as diabetes, cancer, etc. Healing of these wounds could take more than 12 weeks [14]. Acute wounds heal between 8–12 weeks and are caused by trauma, such as stabbing, burns, etc. [13,15]. An acute wound can become chronic when there is a failure of the wound to progress via sequential phases of healing, which can be attributed to biofilm bacteria in the wound, resulting in the wound remaining in the inflammatory phase over a prolonged period. The bacteria stimulate the production of proinflammatory cytokines that recruits mast cells neutrophils and macrophages in the wound. The inflammatory cells try to kill the bacteria by secreting proteases and reactive oxygen species (ROS). However, biofilm bacteria are tolerant to antibiotics, ROS, etc., resulting in an elevated level of ROS and proteases that destroy proteins useful for wound healing [16]. Other factors that make acute wound chronic are repeated episodes of tissue injury, resulting in ischemia, such as in pressure ulcer, venous leg ulcers, poor nutrition, underlying disease, excessive friction, immune status, use of inappropriate wound dressing, and bacterial infections [17]. The process of wound healing is in five phases namely haemostasis, inflammation, migration, proliferation, and remodeling (Figure 1) [4,18,19,20,21,22]. When there is an injury to the skin, haemostasis, and inflammation take place. A major component of the connective tissue of the skin known as fibrinogen helps in the coagulation of the exudates and blood clotting in the wound to stop bleeding [4,13,18,19,20,21,22]. The inflammatory phase occurs simultaneously with the haemostasis phase in which the wound is cleansed of debris and protected from bacterial infection as a result of the release of proteases and reactive oxygen species by the phagocytic cells [4]. The blood monocytes differentiate at the wound site into tissue macrophages releasing growth factors and cytokines recruiting fibroblasts, endothelial cells, and keratinocytes to repair damaged blood vessels [4]. In the migration phase, the epithelial cells move towards the wound site to replace dead cells. In the proliferation stage, the wound is covered completely by epithelium with the formation of granulating tissues. The final phase is the tissue remodeling in which the fibroblasts cover the surface of the wound completely as a new layer of skin. In this phase, there is no evidence of wound and this phase is also referred to as the maturation phase [4,22]. 2.1. Wound Dressing Classification Wound dressing can be classified as traditional, biomaterial-based, interactive, and bioactive dressings (Figure 2) [12]. Traditional dressings are also known as passive wound dressings and they are used to protect wounds from contact with the environment and to stop bleeding [12,13]. Examples of the traditional dressings are gauze and gauze-cotton composites that are characterized by high absorption capacity. However, they can cause bleeding, exhibit poor vapor permeation and damage the newly formed epithelium on removal. The leakage of exudates from these dressings can also result in bacterial infections [12]. Biomaterial-based wound dressings can be further classified as allografts, tissue derivatives, and xenografts [12]. Allografts are skin fragments obtained from donors that are either fresh or freeze-dried and their use is limited by immune reaction resulting in rejection by the body. There is also the risk of infection and transmission of diseases [23,24]. They are expensive with limited shelf life [12,23,24]. Tissue derivatives are obtained from collagen but their use is limited by the